Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study sheds light on equine endothelial cells
“Our methods can now be used by all researchers interested in the topic to further their work” – Elizabeth Finding.
Researchers tested reactions to different growth factors.

A new study has revealed that endothelial cells in horses respond differently to factors that encourage blood vessel growth compared to humans.

Endothelial cells, which line blood vessels, are responsible for the formation of new blood vessels in a process called angiogenesis.

Despite the importance of endothelial cells in many equine diseases and recovery from injury, not much is known about angiogenesis in horses. 

The research team, based at the Royal Veterinary College (RVC), isolated equine endothelial cells and tested how different growth factors stimulated the cells to start the angiogenesis process.

In human
endothelial cells, vascular endothelial growth factor A is the most studied protein. It is sometimes used in cancer treatment in humans. When tested on the equine cells, the study found that it had far less of an effect on the equine cells compared to human cells.

Instead, the tests showed that a different growth factor, fibroblast growth factor 2, caused a much stronger growth response in equine endothelial cells.

As part of the study, the research team also optimised methods for assessing the angiogenic behaviours of equine aortic endothelial cells. The researchers hope their findings will aid further research into both equine and human diseases.

Elizabeth Finding, lecturer in basic sciences at RVC and lead author of the paper, said: “Endothelial cells are crucial to all body systems and the fact that we have known so little about them in the horse up to this stage has limited our ability to study many aspects of equine health and disease.

“Our methods can now be used by all researchers interested in the topic to further their work. I am excited by the possibility that the differences we have found between equine and human endothelial cells may be useful for studying human diseases.”

The study has been published in the International Journal of Molecular Sciences.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.